CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Voriconazole

Last Updated: March 24, 2006
Result type: Reports
Project Number: S0056
Product Line: Common Drug Review

Generic Name: Voriconazole

Brand Name: VFEND

Manufacturer: Pfizer Canada Inc.

Indications: Candidemia

Submission Type: Resubmission 2

Project Status: Complete

Date Recommendation Issued: October 25, 2006

Recommendation Type: List with clinical criteria and/or conditions